Niraparib Rechallenge After Surgery in Ovarian Cancer Patients With Oligometastatic Progression | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Niraparib Rechallenge After Surgery in Ovarian Cancer Patients With Oligometastatic Progression	Adnexal Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, endocrine system disorder, female reproductive system disorder, female reproductive system neoplasm, gonadal disorder, malignant endocrine neoplasm, neoplasm, ovarian cancer, ovarian disorder	Recruiting	Phase 2	2026-04-22		NCT06180356

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
MedSIR	19

14 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Complejo Hospitalario de Jaén	Jaén	Spain	7
Complejo Hospitalario Universitario A Coruña (CHUAC)	A Coruña	Spain	3
Hospital Arnau de Vilanova de Valencia	Valencia	Spain	7
Hospital de Cruces	Barakaldo	Spain	7
Hospital Universitari i Politècnic La Fe	Valencia	Spain	19
Hospital Universitari Sant Joan de Reus	Tarragona	Spain	4
Hospital Universitari Vall d'Hebron	Barcelona	Spain	45
Hospital Universitario 12 De Octubre	Madrid	Spain	98
Hospital Universitario Central de Asturias (HUCA)	Oviedo	Spain	2
Hospital Universitario La Paz	Madrid	Spain	75
Hospital Universitario Ramón y Cajal	Madrid	Spain	42
Hospital Universitario Virgen de la Victoria	Málaga	Spain	24
Hospital Universitario Virgen Macarena	Seville	Spain	25
Institut Català d' Oncologia Girona (ICO)	Girona	Spain	2